Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial
Fierce Pharma
DECEMBER 6, 2022
Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial. Tue, 12/06/2022 - 10:15.
Fierce Pharma
DECEMBER 6, 2022
Vaxxas raises $23M to fund needle-free COVID-19 vaccine trial. Tue, 12/06/2022 - 10:15.
Let's personalize your content